https://www.selleckchem.com/pr....oducts/myf-01-37.htm
The POINT arm had a significant increase in MOUD prescriptions dispensed, non-MOUD prescriptions dispensed, and naloxone access (all p-values 0.001). There was no significant effect related to subsequent drug poisoning-related hospital admissions. The results support the assertion that POINT is meeting its two primary goals related to increasing naloxone access and connecting patients to MOUD. Generalization of these results is limited; however, the evaluation contributes to a nascent area of research and can serve a foundation f
Like
Comment
Share
